Clinical Trial

Evaluation of ICP-B794 in Patients With Advanced Solid Tumors

Name: Evaluation of ICP-B794 in Patients With Advanced Solid Tumors — clinical trial record (NCT07136558)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

An Open-Label, Multi-center, Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ICP-B794 in Patients with Advanced Solid Tumors

Trial Details

NCT Number	NCT07136558
Lead Sponsor	Beijing InnoCare Pharma Tech Co., Ltd.
Conditions	Advanced Solid Tumors
Enrollment	410 participants
Start Date	2025-08
Primary Completion	2029-06 (estimated)
Study Completion	2030-12 (estimated)
Updated on ClinicalTrials.gov	2025-08-22